This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Feb 11:364:l601.

doi: 10.1136/bmj.l601.

Postmenopausal hormone therapy and risk of venous thromboembolism: what about progesterone?

Pierre-Yves Scarabin¹

Affiliations

PMID: 30745295
DOI: 10.1136/bmj.l601

Comment

Postmenopausal hormone therapy and risk of venous thromboembolism: what about progesterone?

Pierre-Yves Scarabin. BMJ. 2019.

. 2019 Feb 11:364:l601.

doi: 10.1136/bmj.l601.

Author

Pierre-Yves Scarabin¹

Affiliation

¹ Inserm U1018, Hôpital Paul Brousse, 94807 Villejuif, France.

PMID: 30745295
DOI: 10.1136/bmj.l601

Erratum in

Postmenopausal hormone therapy and risk of venous thromboembolism: what about progesterone?
[No authors listed] [No authors listed] BMJ. 2019 Feb 19;364:l694. doi: 10.1136/bmj.l694. BMJ. 2019. PMID: 30782600 No abstract available.

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y, Coupland C, Hippisley-Cox J. Vinogradova Y, et al. BMJ. 2019 Jan 9;364:k4810. doi: 10.1136/bmj.k4810. BMJ. 2019. PMID: 30626577 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.